Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial

Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:15:16.000Z thumbnail image
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    8 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a significant update in the study record related to the completion date or outcome measure of a clinical trial for the treatment of advanced triple negative breast cancer.
    Difference
    0.1%
    Check dated 2024-06-06T14:26:00.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for the study, specifying the health conditions and prior treatments required for participants. Additionally, key inclusion and exclusion criteria for the study cohorts have been provided.
    Difference
    17%
    Check dated 2024-05-22T20:32:19.000Z thumbnail image
  8. Check
    45 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:48:49.000Z thumbnail image

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.